Penumbra Executive and Leadership Team

Adam Elsesser, the Chairman & Chief Executive Officer at Penumbra, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the development of neurovascular access systems and aspiration-based thrombectomy technologies, the Chairman & Chief Executive Officer ensures alignment between engineering innovation and clinical market needs. This leadership role involves constant collaboration with the Board to maintain high standards of manufacturing quality across international markets. By prioritizing the expansion of the Neuron and Penumbra System brands, Adam Elsesser drives significant growth in the medical device sector. The Chairman & Chief Executive Officer manages the company's trajectory from the Alameda headquarters, ensuring that every product launch meets stringent regulatory requirements. Through consistent focus on technological advancement, Elsesser secures the company's position as a leader in neurovascular therapies while fostering a culture of continuous improvement and operational excellence.

Maggie Yuen, the Chief Financial Officer at Penumbra, manages the fiscal health and capital allocation strategies required to support global manufacturing operations. Overseeing financial planning, reporting, and investor relations, the Chief Financial Officer ensures that resources remain directed toward high-growth areas like the 3D revascularization device portfolio. This leadership role involves analyzing market trends across North America, Europe, and Asia to optimize revenue streams and maintain profitability. By implementing robust financial controls, Maggie Yuen supports the company's ability to scale production of complex medical devices. The Chief Financial Officer collaborates with executive leadership to evaluate investment opportunities in new neurovascular therapies. Through disciplined management of the balance sheet, Yuen provides the stability necessary for long-term research and development initiatives. Ultimately, the Chief Financial Officer safeguards the financial integrity of the organization while enabling the pursuit of ambitious clinical goals in the competitive medical device landscape.

James Pray, the President, International at Penumbra, executes the commercial strategy for expanding the company's footprint across Europe, Canada, Australia, and Japan. Overseeing regional sales teams and distribution networks, the President, International ensures that neurovascular access systems and thrombectomy devices reach healthcare providers in diverse global markets. This leadership role involves navigating complex regulatory environments and adapting marketing strategies to meet local clinical requirements. By driving international market penetration, James Pray increases the global adoption of the Neuron and Penumbra System brands. The President, International collaborates with the executive team to align regional growth targets with the company's overall manufacturing capacity. Through the development of strategic partnerships with international medical institutions, Pray enhances the company's presence in key geographic regions. Ultimately, the President, International secures long-term growth by delivering high-quality medical device solutions to patients and clinicians on a global scale.

Pankaj Tiwari, the Executive Vice President & Chief Information Officer at Penumbra, architects the digital infrastructure and data systems that power global manufacturing and supply chain logistics. Overseeing the integration of advanced information technology, the Executive Vice President & Chief Information Officer ensures that data-driven insights support the production of neurovascular access systems. This leadership role involves securing critical enterprise networks and optimizing digital workflows to enhance operational efficiency across international regions. By deploying scalable technology solutions, Pankaj Tiwari enables seamless communication between research teams and manufacturing facilities. The Executive Vice President & Chief Information Officer collaborates with other C-suite leaders to align digital transformation efforts with the company's broader mission of improving patient care. Through the implementation of robust cybersecurity protocols, Tiwari protects proprietary intellectual property. Ultimately, the Executive Vice President & Chief Information Officer drives the technological modernization required to maintain a competitive edge in the global medical device market.

James Benenati, the Chief Medical Officer at Penumbra, directs clinical strategy and medical affairs to ensure the safety and efficacy of all neurovascular and vascular device offerings. Overseeing clinical trials and physician engagement, the Chief Medical Officer ensures that products like the 3D revascularization device meet the highest standards of clinical performance. This leadership role involves translating complex medical requirements into actionable product design specifications for the engineering teams. By fostering relationships with leading clinicians across the United States and international markets, James Benenati validates the clinical utility of the company's portfolio. The Chief Medical Officer provides essential guidance on regulatory submissions and medical education programs. Through rigorous evaluation of clinical data, Benenati supports the continuous improvement of aspiration-based thrombectomy systems. Ultimately, the Chief Medical Officer ensures that the company's medical device innovations directly address the most pressing needs of patients and healthcare providers in the neurovascular space.